Mental Health Clinics in E Stroudsburg, PA Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Pocono Therapeutic Services Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 419a King St, E Stroudsburg, PA 18301 Phone: 570-424-8657 Fax: 570-424-9783 |
Water Gap Wellness Recovery Llc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 526 Independence Rd, E Stroudsburg, PA 18301 Phone: 203-524-3039 |
Water Gap Wellness Center Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 232 Independence Rd, E Stroudsburg, PA 18301 Phone: 203-524-3039 |
News Archive
Apellis Pharmaceuticals signs agreement to acquire Potentia Pharmaceuticals
Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
Medical experts launch crowd funding project to investigate effect of malaria drug on colorectal cancer
Medical experts investigating whether a common malaria drug could have a significant impact on colorectal cancer have launched a crowd funding project to fund their work.
New educational initiative aims to help health professionals improve adverse event reporting
A new educational initiative by NPS MedicineWise and the Therapeutic Goods Administration (TGA) aims to improve both the quality and quantity of adverse event reporting relating to medicines, vaccines and medical devices to the TGA.
Proteins involved in fragile X syndrome identified
The interplay of two proteins that bind to messenger RNA, a molecule that mediates translation of the information encoded in genes into proteins, triggers the appearance of fragile X-associated tremor/ataxia syndrome (FTAX), a late-life disorder associated with the gene that causes fragile X syndrome in children, said researchers from Baylor College of Medicine in Houston and Emory University School of Medicine in a report that appears today in the journal Neuron.
CTI submits expanded PIP to EMEA for pixantrone MAA for relapsed or refractory, aggressive NHL
Cell Therapeutics, Inc. announced today that it has submitted an expanded Pediatric Investigation Plan to the European Medicines Agency, as part of the process for its submission for a Marketing Authorization Application for pixantrone in the E.U. for the treatment of relapsed or refractory, aggressive non-Hodgkin's lymphoma (NHL).
› Verified 6 days ago